Ningbo Menovo Pharmaceutical Co., Ltd. (SHA:603538)
China · Delayed Price · Currency is CNY 26.07
+2.37 (10.00%)
Aug 8, 2025, 2:45 PM CST
Ningbo Menovo Pharmaceutical Company Description
Ningbo Menovo Pharmaceutical Co., Ltd. research, develops, produces, and sells pharmaceutical products.
The company’s products portfolio includes valsartan, losartan, clopidogrel, perindopril, rosuvastatin calcium, atorvastatin calcium, purin bahrain, and other products.
It offers APIs, intermediates, and preparations for the treatment of cardiovascular, central nervous system, gastrointestinal tract, and other therapeutic areas.
Ningbo Menovo Pharmaceutical Co., Ltd. was founded in 2004 and is headquartered in Ningbo, China.
Ningbo Menovo Pharmaceutical Co., Ltd.
| Country | China |
| Founded | 2004 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 2,472 |
| CEO | Cheng Zhi Yao |
Contact Details
Address: Building1,Ningbo R&D Park Ningbo, 315048 China | |
| Phone | 86 57 4879 16065 |
| Website | menovopharm.com |
Stock Details
| Ticker Symbol | 603538 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100002Y25 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Cheng Zhi Yao | GM and Chairman |
| Gaofeng Ying | Chief Financial Officer, Board Secretary, Accounting Supervisor and Director |
| Jian Xu | Deputy General Manager |